U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
FARICIMAB
USAN   INN  
Official Name English
FARICIMAB [JAN]
Common Name English
RG-7716
Common Name English
RO6867461
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISUL
Systematic Name English
RO-6867461
Code English
FARICIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA/LAMBDA WITH DOMAIN CROSSOVER, ANTI-(HOMO SAPIENS-VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A, VASCULAR PERMEABILITY FACTOR, VPF)) AND ANTI-(HOMO SAPIENS-ANGIOPOIETIN-2 (ANG-2)), HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY, BIS
Systematic Name English
Faricimab [WHO-DD]
Common Name English
RG7716
Code English
faricimab [INN]
Common Name English
Y8HA1I28D3
Common Name English
RG-7716 (ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR/ANTI-ANGIOPOIETIN 2 BISPECIFIC ANTIBODY)
Common Name English
Code System Code Type Description
NCI_THESAURUS
C174885
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
INN
10563
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
WIKIPEDIA
Faricimab
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
DAILYMED
QC4F7FKK7I
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
DRUG BANK
DB15303
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
EVMPD
SUB194079
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
RXCUI
2591519
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
USAN
FG-178
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
CAS
1607793-29-2
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
FDA UNII
QC4F7FKK7I
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
PRIMARY
CAS
2091719-64-9
Created by admin on Sat Dec 16 14:04:42 GMT 2023 , Edited by admin on Sat Dec 16 14:04:42 GMT 2023
NO STRUCTURE GIVEN